Strategic Innovation Fund, an investment vehicle of Government of Canada, agreed to invest $164m in National Resilience, a company building advanced biopharmaceutical manufacturing ecosystem. “The Government of Canada’s top priority is to protect the health and safety of Canadians. Today’s contribution to Resilience Biotechnologies is another important step to support Canada’s leadership in the life sciences sector and to build future pandemic preparedness. These investments are also creating well-paying jobs and helping to grow Canada’s life sciences ecosystem as an engine for our economic recovery,” François-Philippe Champagne, Minister of Innovation, Science and Industry.